Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy

Radiotherapy and Oncology

Volumn 93, Issue 3, 2009, Pages 414-418

  Gomez, Daniel R ^a   Hunt, Margie A ^a   Jackson, Andrew ^a   O'Meara, William P ^a   Bukanova, Elena N ^a   Zelefsky, Michael J ^a   Yamada, Yoshiya ^a   Rosenzweig, Kenneth E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bronchus; Esophagus; Hypofractionation; Stereotactic body radiation therapy

Indexed keywords

ERLOTINIB;

ADULT; ARTICLE; BRONCHUS DISEASE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ESOPHAGUS DISEASE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SICKNESS; STEREOTACTIC BODY RADIATION THERAPY; THORAX DISEASE; TREATMENT OUTCOME;

AGED; BRONCHI; COUGH; DEGLUTITION DISORDERS; DOSE FRACTIONATION; ESOPHAGUS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PALLIATIVE CARE; PNEUMONIA; RADIATION INJURIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; THORACIC NEOPLASMS;

EID: 70449640453     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.10.017     Document Type: Article

References (17)

1. Wright J.L., et al. Clinical outcomes after reirradiation of paraspinal tumors. Am J Clin Oncol 29 (2006) 495-502
2. Joyner M., et al. Stereotactic body radiation therapy for centrally located lung lesions. Acta Oncol 45 (2006) 802-807
3. Onishi H., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2 (2007) S94-S100
4. Timmerman R., et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 (2003) 1946-1955
5. Nyman J., Johansson K.A., and Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 51 (2006) 97-103
6. Zimmermann F.B., et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 48 (2005) 107-114
7. Timmerman R., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
8. Lovelock D.M., et al. Accurate setup of paraspinal patients using a noninvasive patient immobilization cradle and portal imaging. Med Phys 32 (2005) 2606-2614
9. Spirou S.V., and Chui C.S. A gradient inverse planning algorithm with dose-volume constraints. Med Phys 25 (1998) 321-333
10. Nicolini G., Fogliata A., and Cozzi L. IMRT with the sliding window: comparison of the static and dynamic methods. Dosimetric and spectral analysis. Radiother Oncol 75 (2005) 112-119
11. National Cancer Institute Common Terminology Criteria for Adverse Events, Version 3.0; 2003. Available from: http://ctep.cancer.gov/reporting.
12. Fakiris A.J., McGarry R.C., Yiannoutsos C.T., Papiez L., Williams M., Henderson M.A., and Timmerman R. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 75 (2009) 677-682
13. Hayakawa K., et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 26 (1999) 137-142
14. Jackson A., Yorke E.D., and Rosenzweig K.E. The atlas of complication incidence: a proposal for a new standard for reporting the results of radiotherapy protocols. Semin Radiat Oncol 16 (2006) 260-268
15. Yamashita H., et al. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2 (2007) 21
16. Baumann P., et al. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol 88 (2008) 359-367
17. Kopek N., et al. Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer. Radiother Oncol (2009)